NouvSight001 secures regulatory clearances from the US FDA and China’s NMPA for clinical development in retinitis pigmentosa, ...
Regene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its investigational cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results